More from Practice & Policy

The 2025 SGO meeting will feature readouts of potentially impactful trial data in ovarian cancer, cervical cancer, and other gynecologic malignancies.

Hear from leading cancer experts about the lasting impact the COVID-19 pandemic has left on clinical practice.

Leading multidisciplinary oncology professionals look back at how the COVID-19 pandemic changed cancer care.

A brief overview of the current RCC landscape was provided in the most recent Oncology Decoded podcast.

Testing AI-powered tools globally across diverse patient groups may ensure that they are accurate and consistent for all patients.

The safety profile of vepdegestrant in ER–positive/HER2– breast cancer was consistent with its observed profile in previous studies.